LONZA WALKERSVILLE, INC received a federal award currently valued at $225,400 from Food and Drug Administration. TO DETERMINE IF THE PRESENTED PEPTIDES HAVE THE POTENTIAL OF ELICITING AN IMMUNE RESPONSE BY ACTIVATING CD4+ T CELLS.